Detection of Parvovirus B19 Nucleic Acids and Expression of Viral VP1/VP2 Antigen in Human Colon Carcinoma
Authors:
- 1 July 2007
- journal article
- Published by Wolters Kluwer Health in American Journal of Gastroenterology
- Vol. 102 (7) , 1489-1498
Abstract
The aim of this study was to evaluate whether parvovirus B19, a common infectious pathogen in humans, also was involved in human colon carcinoma. A total of 119 paraffin-embedded specimens of colon polyps, adenocarcinomas, carcinoma-adjacent tissues, and normal controls were processed for nested polymerase chain reaction (PCR), in situ hybridization (ISH), immunohistochemistry (IHC), and laser capture micro dissection detection of B19 DNA and protein. The expression of cyclo-oxygenase-2 (COX-2) in the colon- cancer cells (Lovo) transfected by inducible vector for VP1u was determined by western-blot analysis. B19 DNA was detected in 94.6% (35/37) of colon adenocarcinomas, 67.6% (25/37) of adjacent noncancerous tissues, 85.6% (30/35) of polyps, and 60.0% (6/10) of normal controls by nested PCR, respectively. Analysis of the microdissected material confirmed the presence of viral DNA in colonic neoplastic epithelium. ISH detected B19 DNA in 81.1% (30/37) of colon adenocarcinomas, 43.2% (16/37) of adjacent noncancerous tissues, 74.3% (26/35) of polyps, and 50.0% (5/10) of normal controls, respectively. B19 protein VP1/VP2 was found in 78.4% (29/37), 32.4% (12/37), and 57.1% (20/35) of colon adenocarcinomas, tumor-adjacent tissues, and polyps, respectively, but not in normal colons (none of 10). There were significant differences in nested PCR, ISH, and IHC between adenocarcinoma and non-neoplastic adjacent tissues, and between adenocarcinoma and normal controls. Transfection of colon-cancer cells (Lovo) by inducible vector for VP1u resulted in marked upregulation of cyclo-oxygenase-2 proteins. Parvovirus B19 nucleic acids commonly exist in human colon tissues and VP1/VP2 antigen is preferentially located in colon polyps and adenocarcinomas lesions. B19 viral products VP1u may induce important oncogenic pathways in colon-cancer cells.Keywords
This publication has 27 references indexed in Scilit:
- Activation of Synoviocytes by the Secreted Phospholipase A2Motif in the VP1‐Unique Region of Parvovirus B19 Minor Capsid ProteinThe Journal of Infectious Diseases, 2006
- Colorectal Papillomavirus Infection in Patients with Colorectal CancerClinical Cancer Research, 2005
- Inhibition of NF-κB in cancer cells converts inflammation- induced tumor growth mediated by TNFα to TRAIL-mediated tumor regressionCancer Cell, 2004
- Association of acute parvovirus B19 infection with new onset of acute lymphoblastic and myeloblastic leukaemia: Table 1Journal of Clinical Pathology, 2003
- Epstein–Barr virus infection in colorectal neoplasms associated with inflammatory bowel disease: detection of the virus in lymphomas but not in adenocarcinomasThe Journal of Pathology, 2003
- Human colorectal adenomas demonstrate a size‐dependent increase in epithelial cyclooxygenase‐2 expressionThe Journal of Pathology, 2002
- The VP1 Unique Region of Parvovirus B19 and Its Constituent Phospholipase A2-Like ActivityJournal of Virology, 2002
- In Situ Detection of Epstein-Barr Virus in Gastric and Colorectal AdenocarcinomasAmerican Journal of Surgical Pathology, 1994
- Non-isotopic in situ hybridisation and immunophenotyping of infected cells in the investigation of human fetal parvovirus infection.Journal of Clinical Pathology, 1992
- HUMAN PARVOVIRUS, THE CAUSE OF ERYTHEMA INFECTIOSUM (FIFTH DISEASE)?The Lancet, 1983